The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer

Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 1

Abstract

Cervical cancer is the third most prevalent cancer in women globally, with 529,000 diagnosis and 275,000 deaths each year. It is especially prevalent in developing countries where approximately 85% of cases arise due to the lack of cervical cancer prevention and control programs. In developed countries, where women have access to resources capable of detecting and treating precancerous lesions, the number of cases is reduced by approximately 80%.1 Cervical cancer can be characterised, depending on how far it has spread, from stage 0 (precancerous), also called Cervical Intraepithelial Neoplasia (CIN), where abnormal cells are found in the innermost lining of the cervix and have the potential to become cancerous, through to stage 4, where the cancer has spread to the bladder, rectum or other parts of the body, such as the lungs. In developed countries, there are currently two methods used to prevent cervical cancer from developing to an advanced stage: (1) the distribution of HPV vaccines that are mainly directed against HPV types 16 and 182 and (2) screening methods, such as Papanicolaou test (Pap smear), which involves the collection of exfoliated cells from the cervix, which are then examined for cellular abnormalities. This enables identification of CIN before they begin to develop into cervical cancer.

Authors and Affiliations

Christopher McConville

Keywords

Related Articles

Pregnancy and Childbirth in Patients With Syndrome-MarfanPregnancy and Childbirth in Patients With Syndrome-Marfan

Marfan syndrome (MFS) is an autosomal dominant condition with a reported incidence rate of 1 in 3000 to 5000 individuals. The majority of cases of MFS are caused by a mutation in the fibrillin-1 gene (FBN1). Transforming...

Outcomes and Accuracy of 2D Gray-Scale Ultrasound Scan in Prenatal Diagnosis of Morbid Adherent Placenta

Objective: This study designed to evaluate outcomes and accuracy of 2D gray-scale ultrasound scan in prenatal diagnosis of Morbid Adherent Placenta (MAP). Patients and methods: Fifty pregnant women ≥28 weeks gestation wi...

A Case Report of Solitary Adrenal Metastasis from Early Stage Endometrial Carcinoma

Although Type I endometrial cancers are generally associated with a good prognosis, specific histopathological features portend worse outcomes. Compared to type II tumours which have increased metastatic potential, this...

A Randomized Clinical Trial Study of the Effects of Varicocelectomy on Sperm Clinical Analysis and DNA Fragmentation: A Preliminary Data

Varicocele is a disease characterized by abnormal dilatation of the testicular veins within the pampiniform plexus due to difficult blood return in this region. The prevalence of varicocele is 30 to 40% in infertile men,...

Potential Co-Factor Role of Tobacco Specific Nitrosamine Exposures in the Pathogenesis of Fetal Alcohol Spectrum Disorder

Background: Cerebellar developmental abnormalities in Fetal Alcohol Spectrum Disorder (FASD) are linked to impairments in insulin signaling. However, co-morbid alcohol and tobacco abuses during pregnancy are common. Sinc...

Download PDF file
  • EP ID EP553476
  • DOI 10.17140/GOROJ-2-106
  • Views 179
  • Downloads 0

How To Cite

Christopher McConville (2015). The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer. Gynecology and Obstetrics Research – Open Journal, 2(1), 26-28. https://europub.co.uk/articles/-A-553476